Author:
Mohammad Mohammad Edrees,Vizcarra Joaquin A.,Garcia Xiomara,Patel Shnehal,Margolius Adam,Yu Xin Xin,Fernandez Hubert H.
Reference11 articles.
1. Dopaminergic treatment in Parkinson’s disease: what has each therapeutic family got to offer?;Pagonabarraga;Rev. Neurol.,2014
2. Clinical pharmacology of dopamine agonists;Lam;Pharmacotherapy,2000
3. Clinical pharmacology of dopamine agonists in Parkinson’s disease;Lange;Drugs Aging,1998
4. N. Sáez-Francàs, G. Martí Andrés, N. Ramírez, O. de Fàbregues, J. Álvarez-Sabín, M. Casas, J. Hernández-Vara, Clinical and psychopathological factors associated with impulse control disorders in Parkinson’s disease. Neurologia (Barcelona, Spain) 2015.
5. Meta-analysis of the efficacy and safety of long-acting non-ergot dopamine agonists in Parkinson’s disease;Zhou;J. Clin. Neurosci.,2014
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献